MULLERIAN-INHIBITING SUBSTANCE IS PRESENT IN EMBRYONIC TESTES OF DOGS WITH PERSISTENT MULLERIAN DUCT SYNDROME

被引:27
|
作者
MEYERSWALLEN, VN
LEE, MM
MANGANARO, TF
KURODA, T
MACLAUGHLIN, D
DONAHOE, PK
机构
[1] CORNELL UNIV,COLL VET MED,JA BAKER INST,ITHACA,NY 14853
[2] CORNELL UNIV,COLL VET MED,DEPT CLIN SCI,ITHACA,NY 14853
[3] MASSACHUSETTS GEN HOSP,DEPT PEDIAT SURG,BOSTON,MA 02114
[4] MASSACHUSETTS GEN HOSP,DEPT PEDIAT,BOSTON,MA 02114
关键词
D O I
10.1095/biolreprod48.6.1410
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mullerian Inhibiting Substance (MIS) causes regression of the Mullerian ducts during a critical period in embryonic development in male mammals. In Persistent Mullerian Duct Syndrome (PMDS), an autosomal recessive trait in humans and dogs, the Mullerian ducts fail to regress in otherwise normal males. Previously we reported that PMDS-affected dogs produce bioactive testicular MIS postnatally. The purpose of the present study was to determine whether PMDS-affected canine embryos appropriately express MIS mRNA and protein during the critical period for Mullerian duct regression. Homozygous (PMDS-affected) and normal canine embryos were removed from timed pregnancies. Gonadal sex and the degree of Mullerian duct regression were determined from histologic sections. Positive immunohistochemical staining for MIS was found in testis sections of PMDS-affected and normal male embryos. A 1.8-kb MIS mRNA transcript was detected in testes of PMDS-affected males and normal male embryos and neonates. Furthermore, equal amounts of MIS mRNA transcript were detected in testes of PMDS-affected embryos and normal male littermates during the critical period for Mullerian duct regression. These data support a hypothesis of target organ resistance, such as an abnormality in the putative MIS receptor, as the etiology of the defect in this dog model.
引用
收藏
页码:1410 / 1418
页数:9
相关论文
共 50 条
  • [21] Persistent mullerian duct syndrome
    Portero, S. Simon
    Torres, J. Alfaro
    Idoipe, N. Torrecilla
    Torres, A. Valero
    Latasa, A. B. Roche
    Cebrian, M. A. Trigo
    Rubio, J. I. Franco
    Soriano, M. J. Viso
    Ibanez, I. Marquina
    Cuesta, D. S. Rosero
    VIRCHOWS ARCHIV, 2016, 469 : S220 - S220
  • [22] Persistent Mullerian duct syndrome
    Prakash, Neeraj
    Khurana, Anuj
    Narula, Bhawna
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2009, 52 (04) : 546 - 548
  • [23] PERSISTENT MULLERIAN DUCT SYNDROME
    FERNANDES, ET
    HOLLABAUGH, RS
    YOUNG, JA
    WILROY, SR
    SCHRIOCK, EA
    UROLOGY, 1990, 36 (06) : 516 - 518
  • [24] Persistent Mullerian duct syndrome
    Kane, R.
    Ndiaye, A.
    Dieme, E.
    Ogougbemy, M.
    AFRICAN JOURNAL OF UROLOGY, 2012, 18 (04) : 189 - 191
  • [25] Persistent Mullerian duct syndrome
    Dekker, HM
    de Jong, IJ
    Sanders, J
    Wolf, RFE
    RADIOGRAPHICS, 2003, 23 (02) : 309 - 313
  • [26] Persistent Mullerian duct syndrome
    Rizk, DEE
    Ezimokhai, M
    Hussein, AS
    Gerami, S
    Deb, P
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1998, 261 (02) : 105 - 107
  • [27] Preservation of mullerian structures with laparoscopic management of intra-abdominal testes in persistent mullerian duct syndrome
    Bowen, Diana K.
    Matulewicz, Richard S.
    Gong, Edward M.
    JOURNAL OF PEDIATRIC UROLOGY, 2016, 12 (01) : 65 - 66
  • [28] MULLERIAN-INHIBITING SUBSTANCE FUNCTION DURING MAMMALIAN SEXUAL DEVELOPMENT
    BEHRINGER, RR
    FINEGOLD, MJ
    CATE, RL
    CELL, 1994, 79 (03) : 415 - 425
  • [29] Coincidence of Persistent Mullerian duct syndrome and testicular tumors in dogs
    Park, Eun Jung
    Lee, Seok-Hee
    Jo, Young-Kwang
    Hahn, Sang-Eun
    Go, Do-Min
    Lee, Su-Hyung
    Lee, Byeong-Chun
    Jang, Goo
    BMC VETERINARY RESEARCH, 2017, 13
  • [30] SITES OF TRANSCRIPTION OF THE MULLERIAN-INHIBITING SUBSTANCE GENE IN MOUSE TESTIS
    AO, A
    ERICKSON, RP
    STALVEY, JRD
    MOLECULAR REPRODUCTION AND DEVELOPMENT, 1993, 35 (02) : 159 - 164